FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to urology, and concerns treating detrusor overactivity. Method involves cystoscopy with filling bladder with solution of nitrofural with subsequent injection of solution of botulinum toxin type A directly in detrusor in 20-40 injection points. Wherein solution of nitrofural is preliminarily cooled to temperature of 7-10 °C and selected dose of toxin in physiologic saline is introduced with temperature of 4-8 °C, using 0.5-1.0 ml of dissolved toxin for each injection.
EFFECT: method provides both prevention of hemorrhage in area of surgical manipulations and prevention of postoperative pain syndrome, requiring no additional economic and physical efforts.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF CHILDREN AGED 5 TO 17 YEARS WITH NEUROGENIC DETRUSOR HYPERACTIVITY IN COMBINATION WITH MYELODYSPLASIA AND VASCULAR HYPOTENSION | 2022 |
|
RU2799477C1 |
| METHOD OF TREATING OVERACTIVE BLADDER SYNDROME | 2017 |
|
RU2687106C1 |
| METHOD OF TREATING NEUROGENIC BLADDER DYSFUNCTION MANIFESTED BY FUNCTIONAL INFRAVESICAL OBSTRUCTION IN FEMALES | 2019 |
|
RU2721300C2 |
| METHOD OF TREATING THE NEUROGENIC BLADDER | 2020 |
|
RU2743805C1 |
| BIOPREPARATIONS COMPOSITIONS FOR INTRAVESICAL INSTILLATION | 2015 |
|
RU2720991C2 |
| METHOD OF TREATING HYPERREFLEX DISFUNCTION | 0 |
|
SU1588424A1 |
| IMPROVED BLADDER INJECTION SCHEME FOR ADMINISTRATION OF BOTULINUM TOXINS | 2017 |
|
RU2741966C2 |
| METHOD OF TREATING AND PREVENTING URINATION DISORDERS | 2019 |
|
RU2708524C1 |
| TREATMENT WITH APPLICATION OF BOTULINIC TOXIN | 2004 |
|
RU2350348C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING OVERACTIVE BLADDER IN PATIENTS AND METHOD OF USING SAME | 2023 |
|
RU2827697C1 |
